| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 50.49▼ | 50.50▼ | 50.50▼ | 50.54▼ | 50.62▼ |
| MA10 | 50.50▼ | 50.50▼ | 50.51▼ | 50.51▼ | 50.74▼ |
| MA20 | 50.51▼ | 50.53▼ | 50.54▼ | 50.64▼ | 50.82▼ |
| MA50 | 50.52▼ | 50.54▼ | 50.52▼ | 50.76▼ | 50.71▼ |
| MA100 | 50.53▼ | 50.61▼ | 50.62▼ | 50.83▼ | 50.87▼ |
| MA200 | 50.62▼ | 50.65▼ | 50.73▼ | 50.61▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | -0.004▼ | -0.007▼ | -0.009▼ | -0.047▼ |
| RSI | 27.947▼ | 33.993▼ | 35.732▼ | 39.268▼ | 44.252▼ |
| STOCH | 10.000▼ | 40.212 | 10.526▼ | 31.702 | 24.767 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -85.849▼ | -89.510▼ |
| CCI | -164.657▼ | -150.806▼ | -112.474▼ | -58.827 | -109.006▼ |
| MA | $LONZ Price Crossed Below MA(7) | Set Alert |
|
Monday, November 10, 2025 02:03 PM
VIZZTM (aceclidine ophthalmic solution) 1.44% received FDA approval for the treatment of presbyopia Commercial product launch initiated in October 2025 with broad product availability in mid-Q4 2025 ...
|
|
Saturday, November 08, 2025 05:07 AM
LENZ Therapeutics, Inc. (NASDAQ:LENZ) investors will be delighted, with the company turning in some strong numbers with its latest results. Revenues of US$13m beat estimates by a substantial 169% ...
|
|
Friday, November 07, 2025 01:13 PM
LENZ Therapeutics Inc (LENZ) celebrates a successful product launch and strategic collaborations, despite early-stage challenges and increased expenses.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/11/25 | 50.50 | 50.53 | 50.47 | 50.475 | 147,300 |
| 13/11/25 | 50.56 | 50.60 | 50.505 | 50.52 | 346,300 |
| 12/11/25 | 50.64 | 50.64 | 50.55 | 50.57 | 177,600 |
| 11/11/25 | 50.68 | 50.68 | 50.59 | 50.60 | 98,400 |
| 10/11/25 | 50.55 | 50.564 | 50.495 | 50.54 | 201,379 |
| 07/11/25 | 50.51 | 50.51 | 50.45 | 50.485 | 95,600 |
| 06/11/25 | 50.47 | 50.49 | 50.40 | 50.46 | 542,500 |
| 05/11/25 | 50.48 | 50.54 | 50.42 | 50.475 | 1,190,000 |
| 04/11/25 | 50.47 | 50.51 | 50.4699 | 50.49 | 73,066 |
| 03/11/25 | 50.54 | 50.54 | 50.47 | 50.51 | 177,500 |
|
|
||||
|
|
||||
|
|